Further, we generated TGFβ/SMAD4-regulated gene signatures and utilized an in silico mining approach to correlate the identified signatures with clinical outcome data from two publicly available ovarian cancer patient cohorts. Here, TGFB1 is linked to ovarian carcinoma.